Accepted currencies / methods. Pre-payment in USD, EUR, GBP, RMB, AED or SGD via SWIFT wire, credit card (Visa / Mastercard / AmEx, 2.6% surcharge), Alipay+ (cross-border QR for tourists), WeChat Pay International, and stablecoin USDC on Ethereum/Polygon (institutional only).
Cost transparency. You receive a written, itemised quote before signing the consent form. The quote covers all foreseeable clinical costs (apheresis, manufacturing, lymphodepletion, infusion, ICU if needed, 30-day inpatient stay and 90-day outpatient follow-up) with no hidden fees.
Insurance. We are direct-billing partners with Cigna Global, Aetna International, Bupa Global, Allianz Care, GeoBlue and most ASEAN employers. For patients insured elsewhere we provide a fully itemised English receipt with procedure codes (ICD-10 + CPT where applicable) for out-of-network claim reimbursement.
Refund. If treatment is cancelled before apheresis for medical reasons, all pre-paid amounts are refunded within 14 business days, less non-recoverable third-party costs (≤ USD 1,500).
SaiAo Biotech operates a dedicated International Patient Service Center in Shenzhen. Our case managers respond within 24 hours in English, Arabic, Russian, Vietnamese, Indonesian and Mandarin.
This FAQ is for general informational purposes and does not constitute medical advice. Final treatment decisions must be made by qualified physicians based on full medical records.
Multilingual clinical team. Our International Patient Service Center is staffed by Mandarin/English bilingual case managers, board-certified hematologists who trained in the US/EU, and certified medical translators covering Arabic, Russian, Vietnamese, Indonesian, Thai, Spanish and Farsi.
24/7 bedside interpretation. A dedicated interpreter is on-call during the entire treatment course — pre-admission consultations, consent signing, ward rounds, ICU transfers and discharge planning. Written translations are provided for every informed-consent form, radiology report and discharge summary.
Patient navigators. Each international patient is assigned a single point of contact who handles airport pickup, hotel check-in, hospital admission, pharmacy pickups and accompanying family logistics.
Family updates. Daily English progress notes are emailed to overseas family members upon explicit patient consent.
SaiAo Biotech operates a dedicated International Patient Service Center in Shenzhen. Our case managers respond within 24 hours in English, Arabic, Russian, Vietnamese, Indonesian and Mandarin.
This FAQ is for general informational purposes and does not constitute medical advice. Final treatment decisions must be made by qualified physicians based on full medical records.
Minimum 14-day inpatient monitoring. Per Chinese regulations for cell-therapy, the patient must remain hospitalised for at least 14 days after infusion. During this period CRS and ICANS risk is highest (median onset 1–7 days, but late-onset cases reported up to day 21).
Extended observation criteria. We generally do not allow commercial-airline travel until: (i) ≥ 28 days post-infusion; (ii) CRS / ICANS fully resolved ≥ 7 days; (iii) ANC > 1.5 × 10⁹/L; (iv) platelets > 75 × 10⁹/L without transfusion for 5 days; (v) no active infection; (vi) caregiver in home country confirmed.
Medical clearance letter. Before departure, the attending physician issues a bilingual Fit-to-Fly Medical Clearance acceptable to most airlines, plus a 90-day medication and follow-up plan.
Pre-flight checklist. Avoid flights > 8 hours within 30 days post-infusion. Wear compression stockings, hydrate aggressively, and carry a 14-day emergency supply of tocilizumab / corticosteroids prescribed by our team.
SaiAo Biotech operates a dedicated International Patient Service Center in Shenzhen. Our case managers respond within 24 hours in English, Arabic, Russian, Vietnamese, Indonesian and Mandarin.
This FAQ is for general informational purposes and does not constitute medical advice. Final treatment decisions must be made by qualified physicians based on full medical records.
Hybrid follow-up program. We co-manage with your home-country hematologist / oncologist. The referring physician in your country receives: (i) full English medical record; (ii) bilingual follow-up schedule; (iii) direct phone line to our attending physician for adverse-event escalation.
Standard follow-up cadence. Day 30, 60, 90 — video consultation + labs (CBC, CMP, CRP, ferritin, cytokines). Month 6, 9, 12 — video + imaging + MRD. Annually for 5 years — full restaging.
Digital platform. Patients log vitals, symptoms and lab values in our secure HIPAA/GDPR-compliant portal; abnormal values trigger automatic alerts to our on-call hematologist.
Re-admission pathway. If relapse is suspected, we offer same-week video MDT review and, if needed, expedited visa for re-treatment (same M-visa, fresh PU letter within 48 hours).
SaiAo Biotech operates a dedicated International Patient Service Center in Shenzhen. Our case managers respond within 24 hours in English, Arabic, Russian, Vietnamese, Indonesian and Mandarin.
This FAQ is for general informational purposes and does not constitute medical advice. Final treatment decisions must be made by qualified physicians based on full medical records.
Compliance framework. SaiAo Biotech operates under (i) PRC Personal Information Protection Law (PIPL, 2021); (ii) EU GDPR for EEA patients; (iii) HIPAA-aligned safeguards for US patients; (iv) UAE Federal Decree-Law 45/2021 for GCC patients.
Data localisation. All primary medical records are stored on servers in Shenzhen. Cross-border transfer is minimised — only the records the home-country physician explicitly requests, transmitted via end-to-end-encrypted channels.
Patient consent. A bilingual Personal Information Processing Consent is signed before any data leaves China. Patients may withdraw consent at any time, in which case we delete all non-clinical-accounting records within 30 days.
Breach protocol. In the unlikely event of a breach, we notify the patient and the relevant supervisory authority within 72 hours (GDPR) / 24 hours (PIPL critical infrastructure), with full forensic report.
SaiAo Biotech operates a dedicated International Patient Service Center in Shenzhen. Our case managers respond within 24 hours in English, Arabic, Russian, Vietnamese, Indonesian and Mandarin.
This FAQ is for general informational purposes and does not constitute medical advice. Final treatment decisions must be made by qualified physicians based on full medical records.
